Homebiotech

biotech

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

Elite immune cells lead fight against multiple myeloma

Jim Cornall - May 25, 2026

biotech

COPD focussed AirNexis Therapeutics launches

Jim Cornall - January 20, 2026

biotech

Agentic AI framework launched to improve life sciences decision-making

Jim Cornall - January 20, 2026

biotech

First-in-human drug trial lowers high blood fats

Jim Cornall - January 19, 2026

biotech

New way to disarm antibiotic-resistant bacteria and restore healing in chronic wounds

Jim Cornall - January 19, 2026

biotech

Fast Track designation for geographic atrophy secondary to AMD treatment

Jim Cornall - January 19, 2026

biotech

Base to Base biotech podcast 42: Treating blood cancers, Scottish Brain Sciences and One BioHub Aberdeen, and is speech the new blood?

Jim Cornall - January 16, 2026

biotech

‘Strong’ phase 2 colorectal cancer results

Jim Cornall - January 15, 2026

biotech

Domain Therapeutics rebrands as Kainova Therapeutics

Jim Cornall - January 15, 2026

1...282930...78 Page 29 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026 0

OSE Immunotherapeutics SA has announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026 annual meeting, unveiling topline...

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0

National framework to strengthen UK advanced therapy clinical trials

biotech Jim Cornall - May 25, 2026 0